📈 Jumpstart Signal Watchlist — October 14, 2026

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 At/above 3yr high $60.99 (current $60.99) · ⏳ SMA200 $49.58 (current price $60.99 is above) · 💰 Market Cap $15.2B
- EXEL shows favorable technicals but negative sentiment warrants caution.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (11.8% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 26% (>20%); ROE 47% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 66 showing strength
📢 Sentiment (S): 4/10
- 🗞️ News sentiment is negative (mixed coverage; ✅×1 ❌×2 ⚪️×2).
✅ Exelixis (NASDAQ:EXEL) Hits New 1-Year High — MarketBeat.
🤖 The article reports that EXEL reached a new one-year high, reflecting strong recent share-price momentum. It also notes that analyst sentiment remains mixed, with a consensus Hold rating.
❌ Cancer Drug Spending Is Headed Past $400 Billion as ... — Yahoo Finance.
🤖 The article reports that the FDA extended its review of Exelixis’ zanzalintinib combination for metastatic colorectal cancer by three months, with a new target action date of March 3, 2027. The delay pushes out a potential regulatory catalyst.
❌ Exelixis Inc stock hits all-time high at 61.21 USD — Investing.com.
🤖 The article notes EXEL’s record share price but also reports that the company lowered its full-year revenue guidance and that the FDA extended review of zanzalintinib. Those business and regulatory developments weigh on the outlook despite the stock’s price momentum.
⚪️ Exelixis (EXEL) is a Top-Ranked Growth Stock: Should You Buy? — Zacks.
🤖 Zacks describes EXEL as a growth-stock candidate, noting upward revisions to earnings estimates, but its Zacks Rank remains Hold. The article presents a mixed outlook rather than a clear directional catalyst.
⚪️ Exelixis (NASDAQ:EXEL) Price Target Raised to $54.00 — MarketBeat.
🤖 Truist raised its price target from $52 to $54 but maintained a Hold rating. The higher target is modestly supportive, while the unchanged rating signals continued caution.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 Current $37.46 is 0% below 3yr high $37.54 · ⏳ SMA200 $27.25 (current price $37.46 is above) · 💰 Market Cap $4.8B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (6.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 46% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 69 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×4; showing 3 of 4).
✅ Concentra Group Holdings stock hits all-time high at 38.08 USD — Investing.com.
🤖 Concentra shares reached a record high, reflecting strong recent performance. The article also cites the company’s second-quarter revenue growth, raised full-year outlook, and an S&P credit-rating upgrade.
✅ Concentra Group Holdings Parent (NYSE:CON) Reaches New 52-Week High — MarketBeat.
🤖 The article reports a new 52-week high and describes a broadly bullish analyst consensus with price targets above the share price. It also notes the company’s second-quarter earnings beat and revenue growth.
✅ Concentra Group Holdings Parent (CON) Beats Again And Opens New Occupational Health Center in Daytona Beach — Yahoo Finance.
🤖 The article highlights a new occupational health center that expands Concentra’s footprint, alongside attention from its prior earnings beat. The expansion may support future growth.
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities

🏢 What they do: PC Connection, Inc. (doing business as Connection) is a U.S.-focused information technology solutions provider that helps organizations buy, deploy, secure, and support technology through a value-added reseller and solutions-provider model.
- 🎯 Current $91.68 is 4% below 3yr high $95.22 · ⏳ SMA200 $70.34 (current price $91.68 is above) · 💰 Market Cap $2.3B
- CNXN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 52/60
- 🏦 Low drawdown (11.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 35% (>20%); Low LT D/E 0.00 (<1.0); PEG ratio 0.69 (<1.5).
⏰ Entry (E): 5/20
- 🔔 VWMA trending up (5 consecutive days)
- ⚠️ RSI reversing from overbought (58) — BEARISH
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×4 ❌×1; showing 3 of 5).
✅ Matt Zafirovski Joins Connection as President and Chief Operating Officer — Business Wire.
🤖 Connection appointed Matt Zafirovski president and COO, effective October 12, 2026. The addition of an experienced senior executive may support the company’s leadership and operations.
✅ PC Connection names Matt Zafirovski president and COO — Seeking Alpha.
🤖 The company appointed Zafirovski as president and COO while CEO Timothy McGrath remains in his role. This leadership appointment is a potentially constructive development, though the article reports no specific financial impact.
❌ PC Connection chairman & CAO Patricia Gallup sells $1.23m in shares — Investing.com.
🤖 Chairman and Chief Administrative Officer Patricia Gallup reported selling shares worth about $1.23 million in transactions on October 5 and 6. Insider selling can weigh on sentiment, although the article also notes the stock was near its 52-week high.
🍭 Bonus (B): 0/10 — Computers & Software - Wholesale

🏢 What they do: GigaCloud Technology Inc. (GCT) operates a B2B e-commerce marketplace specializing in large-parcel merchandise like furniture, appliances, and fitness equipment. It provides an end-to-end platform that connects manufacturers (primarily in Asia) with retailers in markets such as the US and Europe, handling product sourcing, logistics, global fulfillment across 39 facilities, sales, and delivery.
- 🎯 At/above 3yr high $57.75 (current $57.75) · ⏳ SMA200 $42.94 (current price $57.75 is above) · 💰 Market Cap $539M
- GCT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 27% (>20%); Revenue growth 28% (>15%); ROE 29% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (5.8%)
- 🔔 Strong above EMA50 (12.4%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 67 showing strength
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×3 ❌×1 ⚪️×1; showing 4 of 5).
✅ GigaCloud Technology (NASDAQ:GCT) Hits New 52-Week High Following Analyst Upgrade — MarketBeat.
🤖 Shares reached a new 52-week high after Wall Street Zen upgraded GigaCloud to Strong Buy. The article also notes that recent quarterly EPS and revenue exceeded analyst expectations.
✅ GigaCloud Technology (NASDAQ:GCT) Stock Lifted to "Strong-Buy" by Wall Street Zen — MarketBeat.
🤖 Wall Street Zen upgraded GigaCloud from Buy to Strong Buy, with other research firms also raising their ratings. The article reports that the company’s recent quarterly results beat consensus estimates.
❌ GigaCloud technology director Bernes sells $990k in shares — Investing.com.
🤖 A company director sold about $990,000 of GigaCloud shares in late September, which may raise concern about insider selling. The article also mentions strong quarterly results and a buyback plan, but the reported transaction is the central news.
⚪️ GigaCloud's (GCT) Growth Story Meets Jim Cramer's Caution — Yahoo Finance.
🤖 The article highlights strong year-over-year growth in second-quarter revenue, net income, and gross margin, but also notes that third-quarter revenue guidance is below the second-quarter total. The mixed growth and guidance signals make the price implications balanced.
🍭 Bonus (B): 0/10 — Catalog & Mail-Order

🏢 What they do: Best Buy Co., Inc. is a consumer electronics retailer that sells products such as computers, mobile phones, appliances, televisions, gaming equipment, and related accessories through its stores and online channels. It also provides technology services, including installation, repair, technical support, and product financing.
- 🎯 Current $89.10 is 14% below 3yr high $103.30 · ⏳ SMA200 $73.50 (current price $89.10 is above) · 💰 Market Cap $18.7B
- BBY shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 70% (>20%); ROE 40% (>15%); Low LT D/E 0.37 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 📈 RSI at 52 in healthy mid-range
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Best Buy (NYSE:BBY) Stock Rating Upgraded by Wall Street Zen — MarketBeat.
🤖 Wall Street Zen upgraded Best Buy from Hold to Buy. The broader analyst consensus remains Hold, tempering the positive signal.
✅ Truist reiterates Buy on Best Buy stock, keeps $100 price target — Investing.com.
🤖 Truist reaffirmed its Buy rating and $100 price target. The article also notes Best Buy’s recent results exceeded expectations, though it mentions a separate downgrade by D.A. Davidson.
⚪️ Best Buy Co. Inc. stock outperforms competitors on strong trading day — MarketWatch.
🤖 Best Buy shares rose 1.30% on October 14, but the article reports only the stock’s daily performance and provides no company-specific catalyst.
🍭 Bonus (B): 0/10 — Radio, TV & Electronics Stores